Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Abbott
Gilead Sciences
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Andrew L. Mason, University of Alberta
ClinicalTrials.gov Identifier:
NCT01614405
First received: April 25, 2011
Last updated: November 11, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)